Archive for March, 2010
LIFE SCIENCES MERGERS AND ACQUISITIONS
March 13th, 2010
in Healthcare, Litigation, Pharmaceuticals / Biotech / Life Sciences |
LEADING INDUSTRY REPRESENTATIVES WILL GIVE YOU VALUABLE INSIGHT REGARDING:
• Evolving industry trends and market deal drivers
• Creating a common vision for a combined business
• Finding the “right” valuation
• Positioning a company to be an attractive acquisition target
• Uncovering potential problems through effective due diligence
• Minimizing antitrust risks and maximizing value
• Drafting agreements that incorporate regulatory concerns
• Evaluating different deal structures and options for the transaction
• Successful integration strategies
As pharma companies compete to develop robust pipelines, M&A activity is a prime concern for the business. Because of the increased price and complexity of collaborations, life sciences companies are using M&As to invest in the next wave of new discoveries, new opportunities, and new partnerships. Make the hard decisions BEFORE beginning any negotiation
Before entering into any M&A transaction, companies need to evaluate the business goals of the transaction, look at market trends, and determine whether an M&A is the most effective course of action for achieving their corporate objectives. Smaller companies must take certain steps to position themselves as attractive acquisition targets. Develop best practices for managing the specific challenges to a life sciences M&A Negotiating M&As in the life sciences arena is significantly different from deals in other industries. For life sciences companies, you need to know how to handle the unique challenges in conducting an accurate due diligence on a pipeline and valuing the assets. In addition, you need to know how to resolve any regulatory issues or antitrust obstacles that arise during the negotiation.
Ensure a smooth transition for the combined businesses Closing the deal is just the beginning of the process. Structuring a workable integration plan is essential to a successful transaction. Reserve your spot today at this invaluable event! With the needs of your company in mind, ACI has developed the 2nd Annual Life Sciences Mergers and Acquisitions conference. A stellar faculty of industry leaders will provide you with the best practices for evaluating, negotiating, and closing successful M&A deals in the life sciences industries. Add value to your attendance by taking advantage of our Ethical, Practical, and Winning Strategies for Negotiating and Drafting Pharma/Biotech M&As. At this in-depth Master Class, you will learn pragmatic strategies and solutions for handling the complex ethical challenges when negotiating mergers or acquisition deals – a great complement to the main event.
Tags: ACI, Legal conferences, life sciences, Litigation strategies
No Comments »
